PT - JOURNAL ARTICLE AU - Nakamura, Hiroyoshi AU - Torimoto, Nao AU - Ishii, Itsuko AU - Ariyoshi, Noritaka AU - Nakasa, Hiromitsu AU - Ohmori, Shigeru AU - Kitada, Mitsukazu TI - CYP3A4 and CYP3A7-Mediated Carbamazepine 10,11-Epoxidation Are Activated by Differential Endogenous Steroids AID - 10.1124/dmd.31.4.432 DP - 2003 Apr 01 TA - Drug Metabolism and Disposition PG - 432--438 VI - 31 IP - 4 4099 - http://dmd.aspetjournals.org/content/31/4/432.short 4100 - http://dmd.aspetjournals.org/content/31/4/432.full SO - Drug Metab Dispos2003 Apr 01; 31 AB - Recently, we reported that several endogenous steroids affect CYP3A4-mediated drug metabolism, using human adult liver microsomes as an enzyme source. Especially, carbamazepine (CBZ) 10,11-epoxidation is activated by androstenedione (AND). In the present studies, we investigated the effects of endogenous steroids on the activity of CBZ 10,11-epoxidation by expressed CYP3A4 and CYP3A7. When expressed CYP3A4 was used as an enzyme source, the addition of AND to the reaction mixture also caused a drastic increase in the activity of CBZ 10,11-epoxidase, and resulted in a change in the kinetics from sigmoid to Michaelis-Menten type. On the other hand, expressed CYP3A7-mediated CBZ 10,11-epoxidation was activated by sulfate conjugate steroids, such as pregnenolone 3-sulfate, 17α-hydroxypregnenolone 3-sulfate, and dehydroepiandrosterone 3-sulfate (DHEA-S), whereas the unconjugated form corresponding to these three steroids did not activate the reaction. Especially, DHEA-S was found to be a potent activator of CBZ 10,11-epoxidation by expressed CYP3A7. The kinetic character of CBZ 10,11-epoxidation by CYP3A7 is Michaelis-Menten type regardless of the presence of DHEA-S. The presence of DHEA-S caused a decrease inKm and increase inVmax for CYP3A7-mediated CBZ 10,11-epoxidation, whereas DHEA-S 16α-hydroxylation was not affected by the coexistence of CBZ. In conclusion, CYP3A4 and CYP3A7-mediated CBZ 10,11-epoxidations are activated by different types of endogenous steroids. This is the first report regarding CYP3A7 cooperativity. The American Society for Pharmacology and Experimental Therapeutics